LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 27

Search options

  1. Article ; Online: GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.

    Frikke-Schmidt, Henriette / Hultman, Karin / Galaske, Joseph W / Jørgensen, Sebastian B / Myers, Martin G / Seeley, Randy J

    Molecular metabolism

    2019  Volume 21, Page(s) 13–21

    Abstract: Objective: Analogues of GDF15 (Growth Differentiation Factor 15) are promising new anti-obesity therapies as pharmacological treatment with GDF15 results in dramatic reductions of food intake and body weight. GDF15 exerts its central anorexic effects by ...

    Abstract Objective: Analogues of GDF15 (Growth Differentiation Factor 15) are promising new anti-obesity therapies as pharmacological treatment with GDF15 results in dramatic reductions of food intake and body weight. GDF15 exerts its central anorexic effects by binding to the GFRAL receptor exclusively expressed in the Area Postrema (AP) and the Nucleus of the Solitary Tract (NTS) of the hindbrain. We sought to determine if GDF15 is an indispensable factor for other interventions that cause weight loss and which are also known to act via these hindbrain regions.
    Methods: To explore the role of GDF15 on food choice we performed macronutrient intake studies in mice treated pharmacologically with GDF15 and in mice having either GDF15 or GFRAL deleted. Next we performed vertical sleeve gastrectomy (VSG) surgeries in a cohort of diet-induced obese Gdf15-null and control mice. To explore the anatomical co-localization of neurons in the hindbrain responding to GLP-1 and/or GDF15 we used GLP-1R reporter mice treated with GDF15, as well as naïve mouse brain and human brain stained by ISH and IHC, respectively, for GLP-1R and GFRAL. Lastly we performed a series of food intake experiments where we treated mice with targeted genetic disruption of either Gdf15 or Gfral with liraglutide; Glp1r-null mice with GDF15; or combined liraglutide and GDF15 treatment in wild-type mice.
    Results: We found that GDF15 treatment significantly lowered the preference for fat intake in mice, whereas no changes in fat intake were observed after genetic deletion of Gdf15 or Gfral. In addition, deletion of Gdf15 did not alter the food intake or bodyweight after sleeve gastrectomy. Lack of GDF15 or GFRAL signaling did not alter the ability of the GLP-1R agonist liraglutide to reduce food intake. Similarly lack of GLP-1R signaling did not reduce GDF15's anorexic effect. Interestingly, there was a significant synergistic effect on weight loss when treating wild-type mice with both GDF15 and liraglutide.
    Conclusion: These data suggest that while GDF15 does not play a role in the potent effects of VSG in mice there seems to be a potential therapeutic benefit of activating GFRAL and GLP-1R systems simultaneously.
    MeSH term(s) Animals ; Area Postrema/metabolism ; Bariatric Surgery ; Body Weight/drug effects ; Diet, High-Fat/adverse effects ; Drug Synergism ; Eating/drug effects ; Gastrectomy ; Gene Deletion ; Glial Cell Line-Derived Neurotrophic Factor Receptors/genetics ; Glial Cell Line-Derived Neurotrophic Factor Receptors/metabolism ; Glucagon-Like Peptide-1 Receptor/metabolism ; Growth Differentiation Factor 15/genetics ; Growth Differentiation Factor 15/metabolism ; Growth Differentiation Factor 15/therapeutic use ; Humans ; Hypoglycemic Agents/therapeutic use ; Liraglutide/therapeutic use ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Obesity/drug therapy ; Obesity/etiology ; Solitary Nucleus/metabolism ; Weight Loss/drug effects
    Chemical Substances GFRAL protein, mouse ; GLP1R protein, human ; Gdf15 protein, mouse ; Glial Cell Line-Derived Neurotrophic Factor Receptors ; Glp1r protein, mouse ; Glucagon-Like Peptide-1 Receptor ; Growth Differentiation Factor 15 ; Hypoglycemic Agents ; Liraglutide (839I73S42A)
    Language English
    Publishing date 2019-01-14
    Publishing country Germany
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 2212-8778
    ISSN (online) 2212-8778
    DOI 10.1016/j.molmet.2019.01.003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pharmacological but not physiological GDF15 suppresses feeding and the motivation to exercise.

    Klein, Anders B / Nicolaisen, Trine S / Ørtenblad, Niels / Gejl, Kasper D / Jensen, Rasmus / Fritzen, Andreas M / Larsen, Emil L / Karstoft, Kristian / Poulsen, Henrik E / Morville, Thomas / Sahl, Ronni E / Helge, Jørn W / Lund, Jens / Falk, Sarah / Lyngbæk, Mark / Ellingsgaard, Helga / Pedersen, Bente K / Lu, Wei / Finan, Brian /
    Jørgensen, Sebastian B / Seeley, Randy J / Kleinert, Maximilian / Kiens, Bente / Richter, Erik A / Clemmensen, Christoffer

    Nature communications

    2021  Volume 12, Issue 1, Page(s) 1041

    Abstract: Growing evidence supports that pharmacological application of growth differentiation factor 15 (GDF15) suppresses appetite but also promotes sickness-like behaviors in rodents via GDNF family receptor α-like (GFRAL)-dependent mechanisms. Conversely, the ... ...

    Abstract Growing evidence supports that pharmacological application of growth differentiation factor 15 (GDF15) suppresses appetite but also promotes sickness-like behaviors in rodents via GDNF family receptor α-like (GFRAL)-dependent mechanisms. Conversely, the endogenous regulation of GDF15 and its physiological effects on energy homeostasis and behavior remain elusive. Here we show, in four independent human studies that prolonged endurance exercise increases circulating GDF15 to levels otherwise only observed in pathophysiological conditions. This exercise-induced increase can be recapitulated in mice and is accompanied by increased Gdf15 expression in the liver, skeletal muscle, and heart muscle. However, whereas pharmacological GDF15 inhibits appetite and suppresses voluntary running activity via GFRAL, the physiological induction of GDF15 by exercise does not. In summary, exercise-induced circulating GDF15 correlates with the duration of endurance exercise. Yet, higher GDF15 levels after exercise are not sufficient to evoke canonical pharmacological GDF15 effects on appetite or responsible for diminishing exercise motivation.
    MeSH term(s) Adult ; Animals ; Appetite Regulation/physiology ; Creatine Kinase/blood ; Creatine Kinase/genetics ; Exercise/physiology ; Feeding Behavior/physiology ; Gene Expression Regulation ; Glial Cell Line-Derived Neurotrophic Factor Receptors/deficiency ; Glial Cell Line-Derived Neurotrophic Factor Receptors/genetics ; Growth Differentiation Factor 15/blood ; Growth Differentiation Factor 15/genetics ; Growth Differentiation Factor 15/metabolism ; Humans ; Interleukin-10/blood ; Interleukin-10/genetics ; Interleukin-6/administration & dosage ; Leptin/blood ; Leptin/genetics ; Liver/drug effects ; Liver/metabolism ; Male ; Mice ; Mice, Knockout ; Motivation/physiology ; Muscle, Skeletal/drug effects ; Muscle, Skeletal/metabolism ; Myocardium/metabolism ; Physical Conditioning, Animal ; Physical Endurance/physiology ; Time Factors
    Chemical Substances GDF15 protein, human ; Gdf15 protein, mouse ; Glial Cell Line-Derived Neurotrophic Factor Receptors ; Growth Differentiation Factor 15 ; IL10 protein, human ; IL6 protein, human ; Interleukin-6 ; LEP protein, human ; Leptin ; Interleukin-10 (130068-27-8) ; Creatine Kinase (EC 2.7.3.2)
    Language English
    Publishing date 2021-02-15
    Publishing country England
    Document type Journal Article ; Observational Study ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-021-21309-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Role of AMPK in skeletal muscle gene adaptation in relation to exercise.

    Jørgensen, Sebastian B / Jensen, Thomas E / Richter, Erik A

    Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme

    2007  Volume 32, Issue 5, Page(s) 904–911

    Abstract: The 5'-AMP-activated protein kinase (AMPK) functions as an intracellular fuel sensor that affects metabolism and gene expression. AMPK is activated in skeletal muscle in response to exercise and is therefore believed to be an important signalling ... ...

    Abstract The 5'-AMP-activated protein kinase (AMPK) functions as an intracellular fuel sensor that affects metabolism and gene expression. AMPK is activated in skeletal muscle in response to exercise and is therefore believed to be an important signalling molecule in regulating adaptation of skeletal muscle to exercise training. This review first focuses on mechanisms regulating AMPK activity during muscle contraction. We then discuss the role of AMPK in regulating expression of genes encoding various enzymes in muscle in the basal state and in relation to exercise training. Although decreased AMPK activity in muscle causes reduced protein expression of mitochondrial enzymes in the basal state, AMPK does not appear to be indispensable for exercise-training induced increase in mitochondrial enzyme expression.
    MeSH term(s) Adaptation, Physiological ; Adenylate Kinase/metabolism ; Exercise/physiology ; Gene Expression Regulation/physiology ; Humans ; Muscle Proteins/genetics ; Muscle Proteins/metabolism ; Muscle, Skeletal/metabolism
    Chemical Substances Muscle Proteins ; Adenylate Kinase (EC 2.7.4.3)
    Language English
    Publishing date 2007-10
    Publishing country Canada
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 2236708-1
    ISSN 1715-5320 ; 1715-5312
    ISSN (online) 1715-5320
    ISSN 1715-5312
    DOI 10.1139/H07-079
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Leukemia inhibitory factor increases glucose uptake in mouse skeletal muscle.

    Brandt, Nina / O'Neill, Hayley M / Kleinert, Maximilian / Schjerling, Peter / Vernet, Erik / Steinberg, Gregory R / Richter, Erik A / Jørgensen, Sebastian B

    American journal of physiology. Endocrinology and metabolism

    2015  Volume 309, Issue 2, Page(s) E142–53

    Abstract: Members of the IL-6 family, IL-6 and ciliary neurotrophic factor (CNTF), have been shown to increase glucose uptake and fatty acid oxidation in skeletal muscle. However, the metabolic effects of another family member, leukemia inhibitory factor (LIF), ... ...

    Abstract Members of the IL-6 family, IL-6 and ciliary neurotrophic factor (CNTF), have been shown to increase glucose uptake and fatty acid oxidation in skeletal muscle. However, the metabolic effects of another family member, leukemia inhibitory factor (LIF), are not well characterized. Effects of LIF on skeletal muscle glucose uptake and palmitate oxidation and signaling were investigated in ex vivo incubated mouse soleus and EDL muscles from muscle-specific AMPKα2 kinase-dead, muscle-specific SOCS3 knockout, and lean and high-fat-fed mice. Inhibitors were used to investigate involvement of specific signaling pathways. LIF increased muscle glucose uptake in dose (50-5,000 pM/l) and time-dependent manners with maximal effects at the 30-min time point. LIF increased Akt Ser(473) phosphorylation (P) in soleus and EDL, whereas AMPK Thr(172) P was unaffected. Incubation with parthenolide abolished LIF-induced glucose uptake and STAT3 Tyr(705) P, whereas incubation with LY-294002 and wortmannin suppressed both basal and LIF-induced glucose uptake and Akt Ser(473) P, indicating that JAK and PI 3-kinase signaling is required for LIF-stimulated glucose uptake. Incubation with rapamycin and AZD8055 indicated that mammalian target of rapamycin complex (mTORC)2, but not mTORC1, also is required for LIF-stimulated glucose uptake. In contrast to CNTF, LIF stimulation did not alter palmitate oxidation. LIF-stimulated glucose uptake was maintained in EDL from obese insulin-resistant mice, whereas soleus developed LIF resistance. Lack of SOCS3 and AMPKα2 did not affect LIF-stimulated glucose uptake. In conclusion, LIF acutely increased muscle glucose uptake by a mechanism potentially involving the PI 3-kinase/mTORC2/Akt pathway and is not impaired in EDL muscle from obese insulin-resistant mice.
    MeSH term(s) Animals ; Biological Transport/drug effects ; Dose-Response Relationship, Drug ; Glucose/metabolism ; Humans ; Leukemia Inhibitory Factor/pharmacology ; Male ; Mice ; Mice, Inbred C57BL ; Muscle, Skeletal/drug effects ; Muscle, Skeletal/metabolism ; Recombinant Proteins/pharmacology ; Signal Transduction/drug effects ; Up-Regulation/drug effects
    Chemical Substances LIF protein, human ; Leukemia Inhibitory Factor ; Recombinant Proteins ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2015-07-15
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00313.2014
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Role of AMPK in skeletal muscle metabolic regulation and adaptation in relation to exercise.

    Jørgensen, Sebastian B / Richter, Erik A / Wojtaszewski, Jørgen F P

    The Journal of physiology

    2006  Volume 574, Issue Pt 1, Page(s) 17–31

    Abstract: The 5'-AMP-activated protein kinase (AMPK) is a potent regulator of skeletal muscle metabolism and gene expression. AMPK is activated both in response to in vivo exercise and ex vivo contraction. AMPK is therefore believed to be an important signalling ... ...

    Abstract The 5'-AMP-activated protein kinase (AMPK) is a potent regulator of skeletal muscle metabolism and gene expression. AMPK is activated both in response to in vivo exercise and ex vivo contraction. AMPK is therefore believed to be an important signalling molecule in regulating muscle metabolism during exercise as well as in adaptation of skeletal muscle to exercise training. The first part of this review is focused on different mechanisms regulating AMPK activity during muscle work such as alterations in nucleotide concentrations, availability of energy substrates and upstream AMPK kinases. We furthermore discuss the possible role of AMPK as a master switch in skeletal muscle metabolism with the main focus on AMPK in metabolic regulation during muscle work. Finally, AMPK has a well established role in regulating expression of genes encoding various enzymes in muscle, and this issue is discussed in relation to adaptation of skeletal muscle to exercise training.
    MeSH term(s) AMP-Activated Protein Kinases ; Adaptation, Physiological/physiology ; Animals ; Energy Metabolism/physiology ; Exercise/physiology ; Humans ; Multienzyme Complexes/metabolism ; Muscle Contraction/physiology ; Muscle, Skeletal/physiology ; Physical Endurance/physiology ; Physical Exertion/physiology ; Protein Serine-Threonine Kinases/metabolism
    Chemical Substances Multienzyme Complexes ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; AMP-Activated Protein Kinases (EC 2.7.11.31)
    Language English
    Publishing date 2006-05-11
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 3115-x
    ISSN 1469-7793 ; 0022-3751
    ISSN (online) 1469-7793
    ISSN 0022-3751
    DOI 10.1113/jphysiol.2006.109942
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Sexual dimorphism in the glucose homeostasis phenotype of the Aromatase Knockout (ArKO) mice.

    Van Sinderen, Michelle / Steinberg, Gregory / Jorgensen, Sebastian B / Honeyman, Jane / Chow, Jenny D Y / Simpson, Evan R / Jones, Margaret E E / Boon, Wah Chin

    The Journal of steroid biochemistry and molecular biology

    2017  Volume 170, Page(s) 39–48

    Abstract: We investigated the effects of estrogens on glucose homeostasis using the Aromatase Knockout (ArKO) mouse, which is unable to convert androgens into estrogens. The ArKO mouse is a model of total estrogen ablation which develops symptoms of metabolic ... ...

    Abstract We investigated the effects of estrogens on glucose homeostasis using the Aromatase Knockout (ArKO) mouse, which is unable to convert androgens into estrogens. The ArKO mouse is a model of total estrogen ablation which develops symptoms of metabolic syndrome. To determine the development and progression of whole body state of insulin resistance of ArKO mice, comprehensive whole body tolerance tests were performed on WT, ArKO and estrogen administrated mice at 3 and 12 months of age. The absence of estrogens in the male ArKO mice leads to hepatic insulin resistance, glucose and pyruvate intolerance from 3 to 12 months with consistent improvement upon estrogen treatment. Estrogen absence in the female ArKO mice leads to glucose intolerance without pyruvate intolerance or insulin resistance. The replacement of estrogens in the female WT and ArKO mice exhibited both insulin sensitizing and resistance effects depending on age and dosage. In conclusion, this study presents information on the sexually dimorphic roles of estrogens on glucose homeostasis regulation.
    MeSH term(s) Animals ; Aromatase/deficiency ; Aromatase/genetics ; Aromatase/metabolism ; Body Mass Index ; Estrogens/metabolism ; Female ; Glucose/metabolism ; Glucose Tolerance Test ; Homeostasis ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Phenotype ; Sex Characteristics
    Chemical Substances Estrogens ; Aromatase (EC 1.14.14.1) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2017-06
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 1049188-0
    ISSN 1879-1220 ; 0960-0760
    ISSN (online) 1879-1220
    ISSN 0960-0760
    DOI 10.1016/j.jsbmb.2016.05.013
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Effects of Estrogens on Adipokines and Glucose Homeostasis in Female Aromatase Knockout Mice.

    Van Sinderen, Michelle L / Steinberg, Gregory R / Jørgensen, Sebastian B / Honeyman, Jane / Chow, Jenny D / Herridge, Kerrie A / Winship, Amy L / Dimitriadis, Evdokia / Jones, Margaret E E / Simpson, Evan R / Boon, Wah Chin

    PloS one

    2015  Volume 10, Issue 8, Page(s) e0136143

    Abstract: The maintenance of glucose homeostasis within the body is crucial for constant and precise performance of energy balance and is sustained by a number of peripheral organs. Estrogens are known to play a role in the maintenance of glucose homeostasis. ... ...

    Abstract The maintenance of glucose homeostasis within the body is crucial for constant and precise performance of energy balance and is sustained by a number of peripheral organs. Estrogens are known to play a role in the maintenance of glucose homeostasis. Aromatase knockout (ArKO) mice are estrogen-deficient and display symptoms of dysregulated glucose metabolism. We aim to investigate the effects of estrogen ablation and exogenous estrogen administration on glucose homeostasis regulation. Six month-old female wildtype, ArKO, and 17β-estradiol (E2) treated ArKO mice were subjected to whole body tolerance tests, serum examination of estrogen, glucose and insulin, ex-vivo muscle glucose uptake, and insulin signaling pathway analyses. Female ArKO mice display increased body weight, gonadal (omental) adiposity, hyperinsulinemia, and liver triglycerides, which were ameliorated upon estrogen treatment. Tolerance tests revealed that estrogen-deficient ArKO mice were pyruvate intolerant hence reflecting dysregulated hepatic gluconeogenesis. Analyses of skeletal muscle, liver, and adipose tissues supported a hepatic-based glucose dysregulation, with a down-regulation of Akt phosphorylation (a key insulin signaling pathway molecule) in the ArKO liver, which was improved with E2 treatment. Concurrently, estrogen treatment lowered ArKO serum leptin and adiponectin levels and increased inflammatory adipokines such as tumour necrosis factor alpha (TNFα) and interleukin 6 (IL6). Furthermore, estrogen deficiency resulted in the infiltration of CD45 macrophages into gonadal adipose tissues, which cannot be reversed by E2 treatment. This study describes the effects of estrogens on glucose homeostasis in female ArKO mice and highlights a primary phenotype of hepatic glucose dysregulation and a parallel estrogen modified adipokine profile.
    MeSH term(s) Adipokines/blood ; Adipose Tissue/metabolism ; Animals ; Aromatase/genetics ; Estradiol/blood ; Estradiol/pharmacology ; Estrogens/blood ; Estrogens/pharmacology ; Female ; Gluconeogenesis ; Glucose/metabolism ; Homeostasis/drug effects ; Interleukin-6/blood ; Leptin/blood ; Liver/metabolism ; Mice ; Mice, Inbred C57BL ; Muscle, Skeletal/metabolism ; Triglycerides/metabolism ; Tumor Necrosis Factor-alpha/blood
    Chemical Substances Adipokines ; Estrogens ; Interleukin-6 ; Leptin ; Triglycerides ; Tumor Necrosis Factor-alpha ; Estradiol (4TI98Z838E) ; Aromatase (EC 1.14.14.1) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2015
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0136143
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Hepatic glucose intolerance precedes hepatic steatosis in the male aromatase knockout (ArKO) mouse.

    Van Sinderen, Michelle L / Steinberg, Gregory R / Jørgensen, Sebastian B / To, Sarah Q / Knower, Kevin C / Clyne, Colin D / Honeyman, Jane / Chow, Jenny D / Herridge, Kerrie A / Jones, Margaret E E / Simpson, Evan R / Boon, Wah Chin

    PloS one

    2014  Volume 9, Issue 2, Page(s) e87230

    Abstract: Estrogens are known to play a role in modulating metabolic processes within the body. The Aromatase knockout (ArKO) mice have been shown to harbor factors of Metabolic syndrome with central adiposity, hyperinsulinemia and male-specific hepatic steatosis. ...

    Abstract Estrogens are known to play a role in modulating metabolic processes within the body. The Aromatase knockout (ArKO) mice have been shown to harbor factors of Metabolic syndrome with central adiposity, hyperinsulinemia and male-specific hepatic steatosis. To determine the effects of estrogen ablation and subsequent replacement in males on whole body glucose metabolism, three- and six-month-old male ArKO mice were subjected to whole body glucose, insulin and pyruvate tolerance tests and analyzed for ensuing metabolic changes in liver, adipose tissue, and skeletal muscle. Estrogen-deficient male ArKO mice showed increased gonadal adiposity which was significantly reduced upon 17β-estradiol (E2) treatment. Concurrently, elevated ArKO serum leptin levels were significantly reduced upon E2 treatment and lowered serum adiponectin levels were restored to wild type levels. Three-month-old male ArKO mice were hyperglycemic, and both glucose and pyruvate intolerant. These phenotypes continued through to 6 months of age, highlighting a loss of glycemic control. ArKO livers displayed changes in gluconeogenic enzyme expression, and in insulin signaling pathways upon E2 treatment. Liver triglycerides were increased in the ArKO males only after 6 months of age, which could be reversed by E2 treatment. No differences were observed in insulin-stimulated ex vivo muscle glucose uptake nor changes in ArKO adipose tissue and muscle insulin signaling pathways. Therefore, we conclude that male ArKO mice develop hepatic glucose intolerance by the age of 3 months which precedes the sex-specific development of hepatic steatosis. This can be reversed upon the administration of exogenous E2.
    MeSH term(s) Adiponectin/blood ; Adipose Tissue/drug effects ; Adipose Tissue/pathology ; Animals ; Aromatase/deficiency ; Aromatase/metabolism ; Blood Glucose/metabolism ; Body Weight/drug effects ; Estrogens/pharmacology ; Gluconeogenesis/drug effects ; Gluconeogenesis/genetics ; Glucose Intolerance/blood ; Glucose Intolerance/enzymology ; Glucose Intolerance/pathology ; Insulin/blood ; Insulin Resistance ; Leptin/blood ; Liver/drug effects ; Liver/metabolism ; Liver/pathology ; Male ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Muscles/metabolism ; Organ Size/drug effects ; Phosphorylation/drug effects ; Pyruvic Acid/metabolism ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Real-Time Polymerase Chain Reaction ; Signal Transduction/drug effects ; Signal Transduction/genetics ; Triglycerides/metabolism
    Chemical Substances Adiponectin ; Blood Glucose ; Estrogens ; Insulin ; Leptin ; RNA, Messenger ; Triglycerides ; Pyruvic Acid (8558G7RUTR) ; Aromatase (EC 1.14.14.1)
    Language English
    Publishing date 2014-02-10
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0087230
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Compensatory regulation of HDAC5 in muscle maintains metabolic adaptive responses and metabolism in response to energetic stress.

    McGee, Sean L / Swinton, Courtney / Morrison, Shona / Gaur, Vidhi / Campbell, Duncan E / Jorgensen, Sebastian B / Kemp, Bruce E / Baar, Keith / Steinberg, Gregory R / Hargreaves, M

    FASEB journal : official publication of the Federation of American Societies for Experimental Biology

    2014  Volume 28, Issue 8, Page(s) 3384–3395

    Abstract: Some gene deletions or mutations have little effect on metabolism and metabolic adaptation because of redundancy and/or compensation in metabolic pathways. The mechanisms for redundancy and/or compensation in metabolic adaptation in mammalian cells are ... ...

    Abstract Some gene deletions or mutations have little effect on metabolism and metabolic adaptation because of redundancy and/or compensation in metabolic pathways. The mechanisms for redundancy and/or compensation in metabolic adaptation in mammalian cells are unidentified. Here, we show that in mouse muscle and myogenic cells, compensatory regulation of the histone deacetylase (HDAC5) transcriptional repressor maintains metabolic integrity. HDAC5 phosphorylation regulated the expression of diverse metabolic genes and glucose metabolism in mouse C2C12 myogenic cells. However, loss of AMP-activated protein kinase (AMPK), a HDAC5 kinase, in muscle did not affect HDAC5 phosphorylation in mouse skeletal muscle during exercise, but resulted in a compensatory increase (32.6%) in the activation of protein kinase D (PKD), an alternate HDAC5 kinase. Constitutive PKD activation in mouse C2C12 myogenic cells regulated metabolic genes and glucose metabolism. Although aspects of this response were HDAC5 phosphorylation dependent, blocking HDAC5 phosphorylation when PKD was active engaged an alternative compensatory adaptive mechanism, which involved post-transcriptional reductions in HDAC5 mRNA (-93.1%) and protein. This enhanced the expression of a specific subset of metabolic genes and mitochondrial metabolism. These data show that compensatory regulation of HDAC5 maintains metabolic integrity in mammalian cells and reinforces the importance of preserving the cellular metabolic adaptive response.
    MeSH term(s) AMP-Activated Protein Kinases/genetics ; AMP-Activated Protein Kinases/physiology ; Acetylation ; Adaptation, Physiological/physiology ; Animals ; Cell Line ; Energy Metabolism/physiology ; Enzyme Activation ; Gene Expression Regulation, Enzymologic/physiology ; Glucose/metabolism ; Histone Deacetylase Inhibitors/pharmacology ; Histone Deacetylases/biosynthesis ; Histone Deacetylases/genetics ; Histone Deacetylases/physiology ; Mice ; Mice, Inbred C57BL ; Muscle Contraction ; Muscle, Skeletal/enzymology ; Myoblasts/metabolism ; Phosphorylation ; Physical Conditioning, Animal/physiology ; Point Mutation ; Protein Kinase C/genetics ; Protein Kinase C/physiology ; Protein Processing, Post-Translational ; RNA, Messenger/biosynthesis ; Recombinant Fusion Proteins/biosynthesis ; Recombinant Fusion Proteins/genetics ; Signal Transduction/physiology ; Transcription, Genetic/physiology ; Transgenes
    Chemical Substances Histone Deacetylase Inhibitors ; RNA, Messenger ; Recombinant Fusion Proteins ; protein kinase D (EC 2.7.10.-) ; Protein Kinase C (EC 2.7.11.13) ; AMP-Activated Protein Kinases (EC 2.7.11.31) ; HDAC5 protein, human (EC 3.5.1.98) ; Histone Deacetylases (EC 3.5.1.98) ; Glucose (IY9XDZ35W2)
    Language English
    Publishing date 2014-08
    Publishing country United States
    Document type Journal Article
    ZDB-ID 639186-2
    ISSN 1530-6860 ; 0892-6638
    ISSN (online) 1530-6860
    ISSN 0892-6638
    DOI 10.1096/fj.14-249359
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: 5'-AMP-activated protein kinase activity and protein expression are regulated by endurance training in human skeletal muscle.

    Frøsig, Christian / Jørgensen, Sebastian B / Hardie, D Grahame / Richter, Erik A / Wojtaszewski, Jørgen F P

    American journal of physiology. Endocrinology and metabolism

    2004  Volume 286, Issue 3, Page(s) E411–7

    Abstract: The 5'-AMP-activated protein kinase (AMPK) is proposed to be involved in signaling pathways leading to adaptations in skeletal muscle in response to both a single exercise bout and exercise training. This study investigated the effect of endurance ... ...

    Abstract The 5'-AMP-activated protein kinase (AMPK) is proposed to be involved in signaling pathways leading to adaptations in skeletal muscle in response to both a single exercise bout and exercise training. This study investigated the effect of endurance training on protein content of catalytic (alpha1, alpha2) and regulatory (beta1, beta2 and gamma1, gamma2, gamma3) subunit isoforms of AMPK as well as on basal AMPK activity in human skeletal muscle. Eight healthy young men performed supervised one-legged knee extensor endurance training for 3 wk. Muscle biopsies were obtained before and 15 h after training in both legs. In response to training the protein content of alpha1, beta2 and gamma1 increased in the trained leg by 41, 34, and 26%, respectively (alpha1 and beta2 P < 0.005, gamma1 P < 0.05). In contrast, the protein content of the regulatory gamma3-isoform decreased by 62% in the trained leg (P = 0.01), whereas no effect of training was seen for alpha2, beta1, and gamma2. AMPK activity associated with the alpha1- and the alpha2-isoforms increased in the trained leg by 94 and 49%, respectively (both P < 0.005). In agreement with these observations, phosphorylation of alpha-AMPK-(Thr172) and of the AMPK target acetyl-CoA carboxylase-beta(Ser221) increased by 74 and 180%, respectively (both P < 0.001). Essentially similar results were obtained in four additional subjects studied 55 h after training. This study demonstrates that protein content and basal AMPK activity in human skeletal muscle are highly susceptible to endurance exercise training. Except for the increase in gamma1 protein, all observed adaptations to training could be ascribed to local contraction-induced mechanisms, since they did not occur in the contralateral untrained muscle.
    MeSH term(s) AMP-Activated Protein Kinases ; Adaptation, Physiological/physiology ; Adult ; Enzyme Activation ; Exercise/physiology ; Exercise Test ; Gene Expression Regulation, Enzymologic/physiology ; Humans ; Isoenzymes/genetics ; Isoenzymes/metabolism ; Knee/physiology ; Male ; Multienzyme Complexes/classification ; Multienzyme Complexes/genetics ; Multienzyme Complexes/metabolism ; Muscle Contraction/physiology ; Muscle, Skeletal/physiology ; Physical Education and Training/methods ; Physical Endurance/physiology ; Protein-Serine-Threonine Kinases/classification ; Protein-Serine-Threonine Kinases/genetics ; Protein-Serine-Threonine Kinases/metabolism
    Chemical Substances Isoenzymes ; Multienzyme Complexes ; PRKAA1 protein, human (EC 2.7.11.1) ; PRKAA2 protein, human (EC 2.7.11.1) ; PRKAB1 protein, human (EC 2.7.11.1) ; PRKAB2 protein, human (EC 2.7.11.1) ; PRKAG1 protein, human (EC 2.7.11.1) ; PRKAG3 protein, human (EC 2.7.11.1) ; Protein-Serine-Threonine Kinases (EC 2.7.11.1) ; AMP-Activated Protein Kinases (EC 2.7.11.31)
    Language English
    Publishing date 2004-03
    Publishing country United States
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 603841-4
    ISSN 1522-1555 ; 0193-1849
    ISSN (online) 1522-1555
    ISSN 0193-1849
    DOI 10.1152/ajpendo.00317.2003
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top